top headlines
Ofichem has agreed to acquire US-based Kinentia Biosciences, expanding its [...]
Movers & Shakers
sponsored content
Other news
AbbVie Ventures joins existing investors in financing to support development [...]
PlaqueTec has recruited 100 patients into its BIOPATTERN trial, which [...]
Yourgene Health has secured Australian regulatory approval for its DPYD [...]
Commit Biologics has nominated COM002, its first development candidate from [...]
Mogrify has generated preclinical proof-of-concept data for an experimental therapy [...]
Nuformix has signed heads of terms to acquire Biovara, adding [...]









